Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 11-20 of 44 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liverColler, J.; Krebsfaenger, N.; Klein, K.; Endrizzi, K.; Wolbold, R.; Lang, T.; Nussler, A.; Neuhaus, P.; Zanger, U.; Eichelbaum, M.; Murdter, T.
2012Implications of central immune signaling caused by drugs of abuse: Mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependenceColler, J.; Hutchinson, M.
2004CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomesHutchinson, M.; Menelaou, A.; Foster, D.; Coller, J.; Somogyi, A.
2012Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in miceWu, Y.; Lousberg, E.; Moldenhauer, L.; Hayball, J.; Coller, J.; Rice, K.; Watkins, L.; Somogyi, A.; Hutchinson, M.
2009Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependenceLiu, L.; Hutchinson, M.; White, J.; Somogyi, A.; Coller, J.
2009Role of active metabolites in the use of opioidsColler, J.; Christrup, L.; Somogyi, A.
2006ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individualsColler, J.; Barratt, D.; Dahlen, K.; Loennechen, M.; Somogyi, A.
2012ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogeneticsBarratt, D.; Coller, J.; Hallinan, R.; Byrne, A.; White, J.; Foster, D.; Somogyi, A.
2014Association of innate immune single-nucleotide polymorphisms with the electroencephalogram during desflurane general anaesthesiaMulholland, C.; Somogyi, A.; Barratt, D.; Coller, J.; Hutchinson, M.; Jacobson, G.; Cursons, R.; Sleigh, J.
2015Pharmacogenetics of opioid responseSomogyi, A.; Coller, J.; Barratt, D.